19-15380373-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000397410.10(AKAP8L):c.1690G>A(p.Gly564Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,570,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000397410.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP8L | NM_014371.4 | c.1690G>A | p.Gly564Ser | missense_variant | 14/14 | ENST00000397410.10 | NP_055186.3 | |
AKAP8L | NM_001291478.2 | c.1507G>A | p.Gly503Ser | missense_variant | 14/14 | NP_001278407.1 | ||
AKAP8L | NR_111971.2 | n.1790G>A | non_coding_transcript_exon_variant | 16/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKAP8L | ENST00000397410.10 | c.1690G>A | p.Gly564Ser | missense_variant | 14/14 | 1 | NM_014371.4 | ENSP00000380557 | P2 | |
ENST00000597164.2 | n.98-682C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000270 AC: 5AN: 185288Hom.: 0 AF XY: 0.0000297 AC XY: 3AN XY: 101028
GnomAD4 exome AF: 0.0000141 AC: 20AN: 1418662Hom.: 0 Cov.: 34 AF XY: 0.0000114 AC XY: 8AN XY: 702730
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.1690G>A (p.G564S) alteration is located in exon 14 (coding exon 14) of the AKAP8L gene. This alteration results from a G to A substitution at nucleotide position 1690, causing the glycine (G) at amino acid position 564 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at